医療用栄養市場- 世界の産業規模、シェア、動向、機会、予測、投与経路別、用途別、エンドユーザー別、地域別、競合市場別、2020-2030F

医療用栄養の世界市場規模は2024年に622億米ドルとなり、予測期間では2030年までCAGR 7.72%で目覚ましい成長が予測されています。

医療用栄養の世界市場には、特定の病状や栄養ニーズに対応するために設計された多様な特殊栄養製品やサプリメントが含まれます。これらの製品は、栄養失調、慢性疾患、胃腸障害など、さまざまな健康上の問題によってオーダーメイドの栄養ソリューションを必要とする個人によって利用されています。例えば、2022年の世界保健機関（WHO）によると、5歳未満の約1億4,900万人の子どもが発育不良と推定され、4,500万人が栄養不良とされています。南アジア・サブリージョンでは、5歳未満の子どもの栄養不良が大きな負担となっています。また、国連の報告によると、アジアの栄養不良人口は2019年の3億6,130万人から2020年には4億1,800万人に増加し、栄養不良の有病率は7.9％から9.0％に増加しています。医療用栄養は、特定の健康状態を管理し、回復を支援し、全体的な幸福を向上させるために、栄養素、調整食、治療用食品製剤を専門的に使用することを指します。栄養不良、慢性疾患、代謝障害、手術や怪我からの回復などを対象としたヘルスケアに不可欠な要素です。医療用栄養には、通常の食事では不十分な場合の経口サプリメント、経腸栄養（経管栄養）、非経口栄養（静脈栄養）が含まれます。医学的管理のもとで設計され、個々の栄養不足に対応し、健康状態を最適化し、合併症を予防します。医療用栄養は、様々な病状の患者の生活の質を高める上で極めて重要な役割を果たしています。

市場促進要因

健康意識の高まり

主な市場課題

厳しい品質保証

主な市場動向

個別化された栄養

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の医療用栄養市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 投与経路別（経口および経腸、非経口）
  • 用途別（栄養失調、代謝障害、胃腸疾患、がん、神経疾患、その他）
  • エンドユーザー別（小児、成人）
  • 地域別
  • 企業別（2024）
• 製品市場マップ
  • 投与経路別
  • 用途別
  • エンドユーザー別
  • 地域別

第6章 北米の医療用栄養市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の医療用栄養市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋地域の医療用栄養市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米の医療用栄養市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの医療用栄養市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Abbott Nutrition Ltd
• Nestle Health Science SA
• Baxter Healthcare Corp
• B Braun SE
• Danone SA
• Perrigo Co PLC
• Fresenius Kabi AG
• AYMES Nutrition
• Reckitt Benckiser Group PLC
• Ajinomoto Cambrooke Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Medical Nutrition Market was valued at USD 62.20 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.72% through 2030. The global medical nutrition market encompasses a diverse range of specialized nutritional products and supplements designed to address specific medical conditions and nutritional needs. These products are utilized by individuals who require tailored nutrition solutions due to various health issues, including malnutrition, chronic diseases, gastrointestinal disorders, and more. For instance, According to the World Health Organization in 2022, approximately 149 million children under the age of 5 were estimated to be stunted, while 45 million were considered wasted globally. The South Asia sub-region bears a significant burden of malnutrition among children under 5 years old. Also, the UN reports that Asia's undernourished population rose from 361.3 million in 2019 to 418.0 million in 2020, with the prevalence of undernourishment increasing from 7.9% to 9.0%. Medical nutrition refers to the specialized use of nutrients, tailored diets, and therapeutic food formulations to manage specific health conditions, support recovery, and improve overall well-being. It is an essential component of healthcare, targeting conditions such as malnutrition, chronic illnesses, metabolic disorders, and recovery from surgeries or injuries. Medical nutrition includes oral supplements, enteral feeding (tube feeding), and parenteral nutrition (intravenous feeding) when regular diets are insufficient. Designed under medical supervision, it addresses individual nutritional deficiencies, optimizes health outcomes, and prevents complications. Medical nutrition plays a pivotal role in enhancing the quality of life for patients across various medical conditions.

Key Market Drivers

Rising Health Awareness

In recent years, a notable shift has occurred in how people perceive health and wellness. There is an increasing awareness of the profound connection between nutrition and well-being, which has significantly contributed to the growth of the global medical nutrition market. This heightened health consciousness is driving individuals to seek specialized nutrition solutions, making the medical nutrition market a dynamic and rapidly expanding industry. For instance, The World Health Organization (WHO) reports that the global population aged 60 and over is projected to grow substantially, increasing from approximately 1 billion in 2020 to about 1.4 billion by 2030. Furthermore, it is expected to nearly double by 2050, reaching around 2.1 billion.

Rising health awareness has prompted a paradigm shift from reactive healthcare to proactive health management. Individuals are increasingly taking charge of their well-being by adopting healthier lifestyles and actively seeking ways to prevent health issues. Medical nutrition plays a crucial role in this shift, offering a means to prevent and manage health conditions through tailored dietary interventions.

Key Market Challenges

Stringent Quality Assurance

Quality assurance is paramount in the medical nutrition market. Ensuring the safety and efficacy of these products is a complex process, with strict standards set by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA). Adherence to these standards is essential to maintain consumer trust, which can be a challenge for smaller manufacturers and new entrants in the market.

Key Market Trends

Personalized Nutrition

Personalization is a dominant trend across the food and nutrition industry, and medical nutrition is no exception. The future of medical nutrition is increasingly individualized, with tailored solutions that account for a person's unique health status, dietary preferences, and genetics. This trend is enabled by the growing understanding of nutrigenomics, which explores how an individual's genes interact with their diet, allowing for precision nutrition recommendations.

Key Market Players

• Abbott Nutrition Ltd
• Nestle Health Science SA
• Baxter Healthcare Corp
• B Braun SE
• Danone SA
• Perrigo Co PLC
• Fresenius Kabi AG
• AYMES Nutrition
• Reckitt Benckiser Group PLC
• Ajinomoto Cambrooke Inc.

Report Scope:

In this report, the Global Medical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Nutrition Market, By Route of Administration:

• Oral and Enteral
• Parenteral

Medical Nutrition Market, By Application:

• Malnutrition
• Metabolic Disorders
• Gastrointestinal Diseases
• Cancer
• Neurological Diseases
• Others

Medical Nutrition Market, By End User:

• Pediatric
• Adult

Medical Nutrition Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medical Nutrition Market.

Available Customizations:

Global Medical Nutrition market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medical Nutrition Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 5.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 5.2.3. By End User (Pediatric, Adult)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Route of Administration
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Medical Nutrition Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 6.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 6.2.3. By End User (Pediatric, Adult)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Medical Nutrition Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Route of Administration
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Medical Nutrition Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Route of Administration
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Medical Nutrition Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Route of Administration
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Medical Nutrition Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 7.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 7.2.3. By End User (Pediatric, Adult)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Medical Nutrition Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Route of Administration
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Medical Nutrition Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Route of Administration
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. France Medical Nutrition Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Route of Administration
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Medical Nutrition Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Route of Administration
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Medical Nutrition Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Route of Administration
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Medical Nutrition Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 8.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 8.2.3. By End User (Pediatric, Adult)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Medical Nutrition Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Route of Administration
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Japan Medical Nutrition Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Route of Administration
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. India Medical Nutrition Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Route of Administration
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Australia Medical Nutrition Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Route of Administration
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. South Korea Medical Nutrition Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Route of Administration
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Medical Nutrition Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 9.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 9.2.3. By End User (Pediatric, Adult)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Medical Nutrition Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Route of Administration
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Medical Nutrition Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Route of Administration
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Medical Nutrition Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Route of Administration
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Medical Nutrition Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 10.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 10.2.3. By End User (Pediatric, Adult)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Medical Nutrition Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Route of Administration
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Medical Nutrition Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Route of Administration
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Medical Nutrition Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Route of Administration
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User
  • 10.3.4. Kuwait Medical Nutrition Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Route of Administration
      • 10.3.4.2.2. By Application
      • 10.3.4.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Abbott Nutrition Ltd
• 14.2. Nestle Health Science SA
• 14.3. Baxter Healthcare Corp
• 14.4. B Braun SE
• 14.5. Danone SA
• 14.6. Perrigo Co PLC
• 14.7. Fresenius Kabi AG
• 14.8. AYMES Nutrition
• 14.9. Reckitt Benckiser Group PLC
• 14.10. Ajinomoto Cambrooke Inc.

15. Strategic Recommendations

16. About Us & Disclaimer